Literature DB >> 10943702

Expression of connexin 31 in the developing mouse cochlea.

A P Xia1, K Ikeda, Y Katori, T Oshima, T Kikuchi, T Takasaka.   

Abstract

Connexin 31 (Cx31) mutations cause an autosomal dominant form of high-frequency hearing loss. The immunohistochemical localization of Cx31 in mouse cochlea was studied at different ages between 0 and 60 days after birth (DAB). Cx31-like immunoreactivity was detected in fibrocytes of spiral ligament and spiral limbus at 12 DAB, gradually enhanced with the increase of age and reached the adult pattern on 60 DAB. Immunoreactivity decreased gradually from the basal to apical turn in all developmental stages. The mRNA of Cx31 was also identified by RT-PCR. The distribution of Cx31 and connexin 26 were obviously different in the developing mouse cochlea. The expression and distribution of Cx31 in the development may explain the progressive hearing loss in human Cx31 mutations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10943702     DOI: 10.1097/00001756-200008030-00022

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  20 in total

Review 1.  Gap junctions in inherited human disease.

Authors:  Georg Zoidl; Rolf Dermietzel
Journal:  Pflugers Arch       Date:  2010-02-07       Impact factor: 3.657

2.  Contractility in type III cochlear fibrocytes is dependent on non-muscle myosin II and intercellular gap junctional coupling.

Authors:  John J Kelly; Andrew Forge; Daniel J Jagger
Journal:  J Assoc Res Otolaryngol       Date:  2012-04-05

3.  Prospective variants screening of connexin genes in children with hearing impairment: genotype/phenotype correlation.

Authors:  Jiann-Jou Yang; Wen-Hung Wang; Yen-Chun Lin; Hsu-Huei Weng; Jen-Tsung Yang; Chung-Feng Hwang; Che-Min Wu; Shuan-Yow Li
Journal:  Hum Genet       Date:  2010-07-01       Impact factor: 4.132

4.  Downregulation of otospiralin, a novel inner ear protein, causes hair cell degeneration and deafness.

Authors:  Benjamin Delprat; Ana Boulanger; Jing Wang; Vicky Beaudoin; Matthieu J Guitton; Stephanie Ventéo; Claude J Dechesne; Rémy Pujol; Mireille Lavigne-Rebillard; Jean-Luc Puel; Christian P Hamel
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

Review 5.  Gap junctions and cochlear homeostasis.

Authors:  H-B Zhao; T Kikuchi; A Ngezahayo; T W White
Journal:  J Membr Biol       Date:  2006-05-17       Impact factor: 1.843

Review 6.  Diverse deafness mechanisms of connexin mutations revealed by studies using in vitro approaches and mouse models.

Authors:  Emilie Hoang Dinh; Shoeb Ahmad; Qing Chang; Wenxue Tang; Benjamin Stong; Xi Lin
Journal:  Brain Res       Date:  2009-02-20       Impact factor: 3.252

7.  Digenic inheritance of non-syndromic deafness caused by mutations at the gap junction proteins Cx26 and Cx31.

Authors:  Xue-Zhong Liu; Yongyi Yuan; Denise Yan; Emilie Hong Ding; Xiao Mei Ouyang; Yu Fei; Wenxue Tang; Huijun Yuan; Qing Chang; Li Lin Du; Xin Zhang; Guojian Wang; Shoeb Ahmad; Dong Yang Kang; Xi Lin; Pu Dai
Journal:  Hum Genet       Date:  2008-12-03       Impact factor: 4.132

8.  Roles of gap junctions in glucose transport from glucose transporter 1-positive to -negative cells in the lateral wall of the rat cochlea.

Authors:  Toshihiro Suzuki; Tatsuya Matsunami; Yasuo Hisa; Kuniaki Takata; Tetsuro Takamatsu; Masahito Oyamada
Journal:  Histochem Cell Biol       Date:  2008-09-12       Impact factor: 4.304

9.  Properties of human connexin 31, which is implicated in hereditary dermatological disease and deafness.

Authors:  Charles K Abrams; Mona M Freidin; Vytas K Verselis; Thaddeus A Bargiello; David P Kelsell; Gabriele Richard; Michael V L Bennett; Feliksas F Bukauskas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

Review 10.  Gap-junction channels dysfunction in deafness and hearing loss.

Authors:  Agustín D Martínez; Rodrigo Acuña; Vania Figueroa; Jaime Maripillan; Bruce Nicholson
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.